当前位置: X-MOL 学术Mol. Cell. Endocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Transcriptional regulation of retinol binding protein 4 by Interleukin-6 via peroxisome proliferator-activated receptor α and CCAAT/Enhancer binding proteins.
Molecular and Cellular Endocrinology ( IF 3.8 ) Pub Date : 2020-01-09 , DOI: 10.1016/j.mce.2020.110702
Muzaida Aminah Mohd 1 , Nur Adelina Ahmad Norudin 2 , Tengku Sifzizul Tengku Muhammad 1
Affiliation  

Interleukin-6 (IL-6) is a major mediator of the acute phase response (APR) that regulates the transcription of acute phase proteins (APPs) in the liver. During APR, the plasma levels of negative APPs including retinol binding protein 4 (RBP4) are reduced. Activation of the IL-6 receptor and subsequent signaling pathways leads to the activation of transcription factors, including peroxisome proliferator-activated receptor alpha (PPARα) and CCAAT/enhancer binding protein (C/EBP), which then modulate APP gene expression. The transcriptional regulation of RBP4 by IL-6 is not fully understood. Therefore, this study aimed to elucidate the molecular mechanisms of PPARα and C/EBP isoforms in mediating IL-6 regulation of RBP4 gene expression. IL-6 was shown to reduce the transcriptional activity of RBP4, and functional dissection of the RBP4 promoter further identified the cis-acting regulatory elements that are responsible in mediating the inhibitory effect of IL-6. The binding sites for PPARα and C/EBP present in the RBP4 promoter were predicted at -1079 bp to -1057 bp and -1460 bp to -1439 bp, respectively. The binding of PPARα and C/EBPs to their respective cis-acting elements may lead to antagonistic interactions that modulate the IL-6 regulation of RBP4 promoter activity. Therefore, this study proposed a new mechanism of interaction involving PPARα and different C/EBP isoforms. This interaction is necessary for the regulation of RBP4 gene expression in response to external stimuli, particularly IL-6, during physiological changes.

中文翻译:

白介素6通过过氧化物酶体增殖物激活受体α和CCAAT /增强剂结合蛋白对视黄醇结合蛋白4的转录调节。

白介素-6(IL-6)是急性期反应(APR)的主要介体,它调节肝脏中急性期蛋白(APPs)的转录。在APR期间,包括视黄醇结合蛋白4(RBP4)的阴性APP的血浆水平降低。IL-6受体的激活和随后的信号通路导致转录因子的激活,包括过氧化物酶体增殖物激活的受体α(PPARα)和CCAAT /增强子结合蛋白(C / EBP),它们随后调节APP基因的表达。IL-6对RBP4的转录调控尚未完全了解。因此,本研究旨在阐明PPARα和C / EBP同工型在介导IL-6调节RBP4基因表达中的分子机制。IL-6被证明可降低RBP4的转录活性,RBP4启动子的功能和功能解剖进一步确定了介导IL-6抑制作用的顺式调节元件。RBP4启动子中PPARα和C / EBP的结合位点分别预测在-1079 bp至-1057 bp和-1460 bp至-1439 bp之间。PPARα和C / EBP与它们各自的顺式作用元件的结合可能导致拮抗相互作用,从而调节RBP4启动子活性的IL-6调节。因此,本研究提出了一种新的相互作用机制,涉及PPARα和不同的C / EBP亚型。在生理变化过程中,这种相互作用对于调节RBP4基因表达是必需的,以响应外部刺激(尤其是IL-6)。RBP4启动子中PPARα和C / EBP的结合位点分别预测在-1079 bp至-1057 bp和-1460 bp至-1439 bp之间。PPARα和C / EBP与它们各自的顺式作用元件的结合可能导致拮抗相互作用,从而调节RBP4启动子活性的IL-6调节。因此,本研究提出了一种新的相互作用机制,涉及PPARα和不同的C / EBP亚型。在生理变化过程中,这种相互作用对于调节RBP4基因表达是必需的,以响应外部刺激(尤其是IL-6)。RBP4启动子中存在的PPARα和C / EBP的结合位点预计分别在-1079 bp至-1057 bp和-1460 bp至-1439 bp之间。PPARα和C / EBP与它们各自的顺式作用元件的结合可能导致拮抗相互作用,从而调节RBP4启动子活性的IL-6调节。因此,本研究提出了一种新的相互作用机制,涉及PPARα和不同的C / EBP亚型。在生理变化过程中,这种相互作用对于调节RBP4基因表达是必需的,以响应外部刺激(尤其是IL-6)。PPARα和C / EBP与它们各自的顺式作用元件的结合可能导致拮抗相互作用,从而调节RBP4启动子活性的IL-6调节。因此,本研究提出了一种新的相互作用机制,涉及PPARα和不同的C / EBP亚型。在生理变化过程中,这种相互作用对于调节RBP4基因表达是必需的,以响应外部刺激(尤其是IL-6)。PPARα和C / EBP与它们各自的顺式作用元件的结合可能导致拮抗相互作用,从而调节RBP4启动子活性的IL-6调节。因此,本研究提出了一种新的相互作用机制,涉及PPARα和不同的C / EBP亚型。在生理变化过程中,这种相互作用对于调节RBP4基因表达是必需的,以响应外部刺激(尤其是IL-6)。
更新日期:2020-01-09
down
wechat
bug